Table 4.
EC50 values of some compounds against TMV.
| Compounds | Curative | Protective | ||||
|---|---|---|---|---|---|---|
| Regression Equation | r | EC50 a (µg/mL) | Regression Equation | r | EC50 a (μg/mL) | |
| 3a | y = 1.0623x + 2.4172 | 0.9996 | 270.0 | / | / | / |
| 3c | y = 1.6326x + 0.8767 | 0.9968 | 335.4 | / | / | / |
| 3h | / | / | / | y = 2.2055x + 0.5493 | 0.9993 | 104.2 |
| 3j | / | / | / | y = 1.3788x + 1.6048 | 0.997 | 290.0 |
| 3l | y = 1.4235x + 1.6149 | 0.9876 | 238.8 | / | / | / |
| 3s | y = 1.0618x + 2.4538 | 0.9977 | 250.0 | / | / | / |
| Ningnanmycin b | y = 1.3750x + 1.4430 | 0.9999 | 386.2 | y = 1.4260x + 1.4280 | 0.9993 | 297.1 |
a Average of three replicates. b The commercial antiviral agent, ningnanmycin.